Assessment of ASGE/ACG Quality Indicators in EGDs Performed at a Tertiary Care Hospital

2017 ◽  
Vol 112 ◽  
pp. S612
Author(s):  
Rashid Z. Syed ◽  
Jacob Breaux ◽  
Muhammad Mubarak ◽  
Kyle E. Wilson ◽  
Usman Rahim ◽  
...  
2019 ◽  
Vol 4 (2) ◽  
pp. 110-115
Author(s):  
Priyanka S Murgod ◽  
◽  
Preeti Rajeev Doshi ◽  
Kunda Jagadale ◽  
Rachana Lakhe ◽  
...  

2012 ◽  
Vol 27 (1) ◽  
pp. 61-68 ◽  
Author(s):  
Rachna Agarwal ◽  
Sujata Chaturvedi ◽  
Neelam Chhillar ◽  
Renu Goyal ◽  
Ishita Pant ◽  
...  

2021 ◽  
Vol 28 (Supplement_1) ◽  
Author(s):  
L Perez De Isla ◽  
JC Gomez Polo ◽  
A Salinas Gallegos ◽  
P Mahia Casado ◽  
A Viana Tejedor ◽  
...  

Abstract Funding Acknowledgements Type of funding sources: Private grant(s) and/or Sponsorship. Main funding source(s): Sanofi Aventis S.A. Introduction Optimisation of the care of patients after an acute coronary syndrome (ACS) is a fundamental step to improve health outcomes and avoid consecutive cardiovascular events however data on how care is provided is often absent. Purpose Our objective was to analyse the main quality indicators in the post-ACS patient pathway so as to determine the actions which avoid future CDV events. Methods In a random sample of 100 patients between January 2018 and December 2019, we selected the indicators which most affect secondary prevention in patients post-ACS. All patients had been diagnosed with ACS within a tertiary-care hospital with a 24h interventional cardiology lab.  The indicators were retrospectively analysed using the patients’ health record. Results The main results are presented in Table 1. Conclusions Based on this, we proposed an integrated protocol for all patients post-ACS which will begin in 2021 within this tertiary-care hospital. Within this protocol, the information contained in the discharge report will be improved and automatized as much as possible so as re-evaluate at a later date. Table 1: Demographics and results Title of the indicator Yes (%) No (%) Men 76 24 STEMI 40 60 NSTEMI 60 40 Dual antiplatelet therapy included in discharge report 100 0 High doses statins at discharge 98 2 BMI included in discharge report 0 100 LDL objective included in discharge report 14 86 HbA1c objective included in discharge report 13 87 Physical activity included in discharge report 15 85 Flu vaccination recomendations included in discharge report 0 100 Complete blood analysis completed 4-6 weeks after discharge 100 0 Blood pressure is measured on first post-discharge consultation 100 0 Blood pressure medication is changed on first post-discharge consultation 28 78 Patient arrives with measurement for HbA1c on first post-discharge consultation 78 22 Antidiabetic medication is modified on first post-discharge consultation 8 92 BMI is registered on first post-discharge consultation 0 100 Patients with LDL below 55mg/dl on first post-discharge consultation 29 71 Lipid-lowering medications is changed on first post-discharge consultation 29 71


Vacunas ◽  
2020 ◽  
Vol 21 (2) ◽  
pp. 95-104 ◽  
Author(s):  
Y.M. AlGoraini ◽  
N.N. AlDujayn ◽  
M.A. AlRasheed ◽  
Y.E. Bashawri ◽  
S.S. Alsubaie ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document